RBC Life Sciences, Inc.
RBCL
$0.0001
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 21.22% | -38.95% | 10.97% | -20.52% | -23.02% |
| Total Depreciation and Amortization | -12.88% | -5.55% | -4.73% | -1.43% | 0.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -655.42% | 12.24% | 30.69% | 42.06% | -141.05% |
| Change in Net Operating Assets | 15.43% | -71.43% | 1,303.04% | -210.43% | -172.59% |
| Cash from Operations | -84.21% | -412.20% | 93.67% | -306.52% | -198.38% |
| Capital Expenditure | 65.92% | 46.66% | -41.61% | -302.25% | -9,610.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.00% | -- | -- | -- | -- |
| Cash from Investing | 483.53% | 46.66% | -41.61% | -302.25% | -9,959.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -471.50% | -7.97% | -7.98% | -8.03% | -7.92% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -471.22% | 0.76% | 0.92% | 1.02% | 1.18% |
| Foreign Exchange rate Adjustments | 1,603.83% | 252.01% | 294.91% | 90.00% | -47.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.63% | -22.22% | 28.47% | -1,112.16% | -307.38% |
